Medtech manufacturing industry divided on policy for devices
The Centre’s plan to form a new import policy for refurbished high-end medical devices has divided the medtech manufacturing industry. This comes even as imports continue despite a lack of regulation for the devices.
The multinational company (MNC) representative bodies have welcomed the policy review as a means to expand affordable healthcare, while domestic manufacturers say the step could risk patient safety and provide a threat to local manufacturers.
Domestic device makers body Association of Indian Medical Device Industry (AiMeD) on Monday said that they are against any move to reconsider or relax policy curbs on importing refurbished or pre-owned medical equipment, especially without an enforceable regulatory framework benchmarked to global standards.
